top of page

fresnel lens hero.jpg

News & Events

background (41).jpg

January 10, 2025

Frenelle Pharma Officially Launches: CEO Missling Attends JPM 2025 Representing Frenelle’s Portfolio

November 25, 2024

SpineThera Celebrates Milestone Achievement with 7th Patent Issued by the US Patent and Trademark Office

June 17, 2024

SpineThera, Inc. to collaborate with Mayo Clinic to advance solutions in substance abuse disorder treatment

May 1, 2024

Anumio has been selected as one of the ten Technology Village Finalists at the upcoming Animal Health, Nutrition and Technology Innovation conference being held Jun 11-13 in Boston, MA

April 16, 2024

Anumio is awarded a Launch Minnesota Innovation Grant

April 3, 2024

ProMed Pharma Acquires SpineThera Manufacturing Capabilities and an Option to License Intellectual Property

October 5, 2023

SpineThera Celebrates Milestone Achievement with 6th Patent Issued by the US Patent and Trademark Office

September 25, 2023

SpineThera SALIENT Clinical Trial Results to Be Presented at Upcoming 22nd Annual ASRA Pain Medicine Meeting

September 6, 2023

SpineThera Announces Breakthrough Market Research Results for SX600 in the Management of Sciatica Pain

December 7, 2022

SpineThera Announces Results for SX600 from its SALIENT Phase 2 Sciatica Pain Clinical Trial Supporting the Potential for Best-In-Class Therapy

May 16, 2022

Doug Drysdale and Dr. Shaheen Lakhan Join SpineThera Board

April 26, 2022

SpineThera Awarded $5 Million Grant From Department of Defense

yes lens fade.jpg

bottom of page